Announcements Trials
Browse Landscape

Phase

Phase 4 2

Status

Active not recruiting 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Conditions

Papillomavirus Infections 2Uterine Cervical Neoplasms 1Cervical Cancer Screening 1

Interventions

Specimen Handling 7Radiotherapy, Intensity-Modulated 5Human Papillomavirus Recombinant Vaccine nonavalent 5Human Papillomavirus DNA Tests 5Colposcopy 5Cisplatin 5Patient Navigation 3Methods 3Early Intervention, Educational 3Carboplatin 3human papillomavirus vaccine, L1 type 16, 18 2epigallocatechin gallate 2artesunic acid 2artemisinin 2Standard of Care 2Practice Guidelines as Topic 2Papillomavirus Vaccines 2Mass Screening 2Educational Status 2Docetaxel 2Cytological Techniques 2Blood Specimen Collection 2toripalimab 1fludarabine phosphate 1fludarabine 1artenimol 1aldesleukin 1adacel 1Watchful Waiting 1Vitamin B 12 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Papillomavirus Infections × Papillomavirus Vaccines × 1 year × Clear all
NCT04235257 2026-05-05

Intradermal, Fractional Dose of HPV Vaccines:

University of Washington

Phase 4 Active not recruiting
40 enrolled

Papillomavirus Infections

NCT05291871 2026-05-05

Immunogenicity of Fractional Dose of the HPV Vaccines

University of Washington

Phase 4 Active not recruiting
92 enrolled

Papillomavirus Infections

Data powered by HemOnc (CC BY 4.0) Colophon âš¡